Status:
COMPLETED
Risk Stratification With Chest CT to Rule-out Suspected SARS-CoV-2 Infections
Lead Sponsor:
Jena University Hospital
Conditions:
Severe Acute Respiratory Syndrome Coronavirus 2
Eligibility:
All Genders
18+ years
Brief Summary
The study objective is to investigate the diagnostic value and consistency of chest CT as compared with comparison to RT-PCR assay in COVID-19 in patients which were stratified for hospital admission.
Detailed Description
To prevent spreading of the new coronavirus (SARS-CoV-2) from patients who are infected but in whom infection was not detected by means of Reverse transcription polymerase chain reaction (RT-PCR) and ...
Eligibility Criteria
Inclusion
- ≥ 18 years
- Provided written informed consent
- Intended hospital admission for any reason
- Symptoms that suggest infection with SARS-CoV-2
- Participant agrees to rt PCR and antibody test (SARS-CoV-2)
Exclusion
- \< 18 years
- Pregnancy cannot be excluded
Key Trial Info
Start Date :
April 15 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2020
Estimated Enrollment :
145 Patients enrolled
Trial Details
Trial ID
NCT04357938
Start Date
April 15 2020
End Date
June 30 2020
Last Update
September 20 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jena University Hospital
Jena, Thuringia, Germany, 07747